TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data Private Market Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Altos Labs Stock

Altos Labs Stock

altoslabs.comHealthcareFounded: 2021Funding to Date: $1.16B

Altos Labs is an American biotechnology research company founded in 2022 and focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine. Altos has operations in San Francisco, San Diego, and in Cambridge, UK, with significant collaborations in Japan, with a Board of Directors and advisors including Nobel Laureates and scientific leaders.

Buy or sell Altos Labs stockLearn more about Altos Labs IPO
Register for Details

For more details on financing and valuation for Altos Labs, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Altos Labs.

Register Today

Altos Labs investors also invested in these private companies

Arch Venture Partners
Foresite Capital
Mubadala Investment Company

Team

Management Team

Hans Bishop
Co-Founder & President
Ann Lee-Karlon Ph.D
Chief Operating Officer
Hal Barron MD
Chief Executive Officer
Richard Klausner MD
Co-Founder & Chief Scientist

Other companies like Altos Labs in the Healthcare sector

Acelyrin
Sector
Healthcare
Last Round Est. Valuation
$809.52MM
Colossal Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.01B
Paradromics
Sector
Healthcare
 
 
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Artera
Sector
Healthcare
Last Round Est. Valuation
$396.01MM
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Alzheon
Sector
Healthcare
Last Round Est. Valuation
$1.53B
Emulate
Sector
Healthcare
Last Round Est. Valuation
$409.37MM

News

PR Newswire 01/19/2022
Altos Labs launches with the goal to transform medicine through cellular rejuvenation programming
Altos Labs™ (Altos™) launched today as a new biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation programming. Altos' mission is to restore cell health and resilience to reverse disease, injury, and the disabilities that can occur throughout life. The company launches with a community of leading scientists, clinicians, and leaders from both academia and industry working together towards this common mission.

Trending Companies

Frequently Asked Questions